Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock

Download

• Small JPEG, 327x154, 6.4 KB
• Preview JPEG, 144x68, 2.7 KB
• Thumbnail JPEG, 120x57, 2.1 KB